Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications

COLLEYVILLE, Texas--(BUSINESS WIRE)--Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today that it has received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT. Mg OSTEOINJECT is the first drillable, adhesive, and injectable bone void filler in the U.S. to incorporate magnesium, a critical component for bone health and development. The expanded indication includes use of the material as an adjunct to hardware fixation